Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy

Waldhauer, I.
Gonzalez-Nicolini, Valeria
Freimoser-Grundschober, A.
Nayak, T.K.
Fahrni, Linda
Hosse, R.J.
Gerrits, D.
Geven, E.J.W.
Boerman, O.C.
Umana, P.
Klein, Christian

Publication date

January 2021

DOI

10.1080/19420862.2021.1913791

Publisher

Informa UK Limited

Language

English

Abstract

Contains fulltext : 233611.pdf (Publisher’s version ) (Open Access

Extracted data

Topics

Related items

Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy

Pretto, Francesca
Elia, Giuliano
Castioni, Nadia
Neri, Dario

September 2014

Antibody-cytokine fusion proteins (“immunocytokines”) represent a promising class of armed antibody ...

Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma.

Brouwers, A.H.
Frielink, C.
Oosterwijk, E.
Oyen, W.J.G.
Corstens, F.H.M.
Boerman, O.C.

January 2003

Item does not contain fulltextBACKGROUND: Interleukin-2 (IL-2) and interferon-alpha (IFN-alpha) can ...

Molecularly defined dendritic cell-targeted vaccines for cancer immunotherapy

Fennemann, F.L.

January 2021

Contains fulltext : 235389.pdf (Publisher’s version ) (Open Access)Radboud Univers...

Cellular immunotherapy in hematological malignancies

Roeven, M.W.H.

January 2017

Contains fulltext : 178256.pdf (publisher's version ) (Open Access)Radboud Univers...

Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study

Punt, C.J.A.
Herpen, C.M.L. van
Jansen, R.L.H.
Vreugdenhil, A.
Muller, E.W.
Mulder, P.H.M. de

January 1997

Contains fulltext : 25471.PDF (publisher's version ) (Open Access

Sialic acid mimetics for cancer immunotherapy

Büll, C.

January 2017

Contains fulltext : 169260.pdf (publisher's version ) (Open Access)Radboud Univers...

DataSheet_1_Potent immunomodulatory and antitumor effect of anti-CD20-IL2no-alpha tri-functional immunocytokine for cancer therapy.pdf

Ana Victoria Casadesús (14238776)
Beatriz María Cruz (14238779)
Wilden Díaz (14238782)
Miguel Ángel González (14238785)
Tania Gómez (14238788)
Briandy Fernández (14238791)
Addys González (14238794)
Nuris Ledón (4266283)
Katya Sosa (14238797)
Kathleen Castro (14238800)
Armando López (541227)
Claudia Plasencia (14238803)
Yaima Ramírez (14238806)
Jean-Luc Teillaud (154584)
Calixto Hernández (14238809)
Kalet León (2795161)
Tays Hernández (14238812)

December 2022

IntroductionThe anti-CD20 antibody rituximab (RTX) has substantially improved outcomes of patients w...

The role of monoclonal antibody affinity in tumor immunotherapy evaluated in in vivo models for minimal residual disease

Velders, M.P.
Rhijn, C.M. van
Cornelissen, I.M.H.A.
Muijen, G.N.P. van
Briaire, I.H.
Dohlsten, M.
Fleuren, G.J.
Warnaar, S.O.
Litvinov, S.V.

January 1996

Contains fulltext : 23197___.PDF (publisher's version ) (Open Access

Hematopoietic stem cell-derived products for cancer immunotherapy

Thordardottir, S.

January 2018

Contains fulltext : 187354.pdf (publisher's version ) (Open Access)Radboud Univers...

Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell Activity

Kroon, Paula
Frijlink, Elselien
Iglesias-Guimarais, V.
Volkov, A.E.
Buuren, M.M. van
Schumacher, Ton N.
Verheij, M.
Borst, J.
Verbrugge, Inge

January 2019

Contains fulltext : 202601.pdf (publisher's version ) (Closed access

Improving cancer immunotherapy by targeting the STATe of MDSCs

Haas, N. de
Koning, C.
Spilgies, L.
Vries, I.J.M. de
Hato, S.V.

January 2016

Contains fulltext : 172778.pdf (Publisher’s version ) (Open Access)Cancer immunoth...

Locoregional immunotherapy with interleukin-2 in head and neck squamous-cell carcinoma: preclinical and clinical studies

Mattijssen, E.J.M.

January 1994

Contains fulltext : mmubn000001_179491989.pdf (publisher's version ) (Open Access)...

Presentation_1_The combination of IL-2 nanoparticles and Palbociclib enhances the anti-tumor immune response for colon cancer therapy.pdf

Di Wang (329735)
Xiaoshuang Wang (631438)
Yingyu Zhang (7846409)
Le Yu (227543)
Jing An (74610)
Xiaodong Wang (66801)
Yue Huang (285485)
Xuemei Han (384322)

January 2024

Immunotherapy of tumors plays a pivotal role in the current treatment of cancer. While interleukin 2...

Blocking IL-1 beta reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation

Kaplanov, Irena
Carmi, Yaron
Kornetsky, Rachel
Shemesh, Avishai
Shurin, Galina V.
Shurin, Michael R.
Dinarello, C.A.
Voronov, E.
Apte, R.N.

January 2019

Contains fulltext : 200871.pdf (publisher's version ) (Closed access

Immunocytokines: the long awaited therapeutic magic bullet in rheumatoid arthritis?

Loo, F.A.J. van de
Berg, W.B. van den

January 2009

Contains fulltext : 80373.pdf (publisher's version ) (Open Access

Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy

Pretto, Francesca
Elia, Giuliano
Castioni, Nadia
Neri, Dario

September 2014

Antibody-cytokine fusion proteins (“immunocytokines”) represent a promising class of armed antibody ...

Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma.

Brouwers, A.H.
Frielink, C.
Oosterwijk, E.
Oyen, W.J.G.
Corstens, F.H.M.
Boerman, O.C.

January 2003

Item does not contain fulltextBACKGROUND: Interleukin-2 (IL-2) and interferon-alpha (IFN-alpha) can ...

Molecularly defined dendritic cell-targeted vaccines for cancer immunotherapy

Fennemann, F.L.

January 2021

Contains fulltext : 235389.pdf (Publisher’s version ) (Open Access)Radboud Univers...

Cellular immunotherapy in hematological malignancies

Roeven, M.W.H.

January 2017

Contains fulltext : 178256.pdf (publisher's version ) (Open Access)Radboud Univers...

Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study

Punt, C.J.A.
Herpen, C.M.L. van
Jansen, R.L.H.
Vreugdenhil, A.
Muller, E.W.
Mulder, P.H.M. de

January 1997

Contains fulltext : 25471.PDF (publisher's version ) (Open Access

Sialic acid mimetics for cancer immunotherapy

Büll, C.

January 2017

Contains fulltext : 169260.pdf (publisher's version ) (Open Access)Radboud Univers...

DataSheet_1_Potent immunomodulatory and antitumor effect of anti-CD20-IL2no-alpha tri-functional immunocytokine for cancer therapy.pdf

Ana Victoria Casadesús (14238776)
Beatriz María Cruz (14238779)
Wilden Díaz (14238782)
Miguel Ángel González (14238785)
Tania Gómez (14238788)
Briandy Fernández (14238791)
Addys González (14238794)
Nuris Ledón (4266283)
Katya Sosa (14238797)
Kathleen Castro (14238800)
Armando López (541227)
Claudia Plasencia (14238803)
Yaima Ramírez (14238806)
Jean-Luc Teillaud (154584)
Calixto Hernández (14238809)
Kalet León (2795161)
Tays Hernández (14238812)

December 2022

IntroductionThe anti-CD20 antibody rituximab (RTX) has substantially improved outcomes of patients w...

The role of monoclonal antibody affinity in tumor immunotherapy evaluated in in vivo models for minimal residual disease

Velders, M.P.
Rhijn, C.M. van
Cornelissen, I.M.H.A.
Muijen, G.N.P. van
Briaire, I.H.
Dohlsten, M.
Fleuren, G.J.
Warnaar, S.O.
Litvinov, S.V.

January 1996

Contains fulltext : 23197___.PDF (publisher's version ) (Open Access

Hematopoietic stem cell-derived products for cancer immunotherapy

Thordardottir, S.

January 2018

Contains fulltext : 187354.pdf (publisher's version ) (Open Access)Radboud Univers...

Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell Activity

Kroon, Paula
Frijlink, Elselien
Iglesias-Guimarais, V.
Volkov, A.E.
Buuren, M.M. van
Schumacher, Ton N.
Verheij, M.
Borst, J.
Verbrugge, Inge

January 2019

Contains fulltext : 202601.pdf (publisher's version ) (Closed access

Improving cancer immunotherapy by targeting the STATe of MDSCs

Haas, N. de
Koning, C.
Spilgies, L.
Vries, I.J.M. de
Hato, S.V.

January 2016

Contains fulltext : 172778.pdf (Publisher’s version ) (Open Access)Cancer immunoth...

Locoregional immunotherapy with interleukin-2 in head and neck squamous-cell carcinoma: preclinical and clinical studies

Mattijssen, E.J.M.

January 1994

Contains fulltext : mmubn000001_179491989.pdf (publisher's version ) (Open Access)...

Presentation_1_The combination of IL-2 nanoparticles and Palbociclib enhances the anti-tumor immune response for colon cancer therapy.pdf

Di Wang (329735)
Xiaoshuang Wang (631438)
Yingyu Zhang (7846409)
Le Yu (227543)
Jing An (74610)
Xiaodong Wang (66801)
Yue Huang (285485)
Xuemei Han (384322)

January 2024

Immunotherapy of tumors plays a pivotal role in the current treatment of cancer. While interleukin 2...

Blocking IL-1 beta reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation

Kaplanov, Irena
Carmi, Yaron
Kornetsky, Rachel
Shemesh, Avishai
Shurin, Galina V.
Shurin, Michael R.
Dinarello, C.A.
Voronov, E.
Apte, R.N.

January 2019

Contains fulltext : 200871.pdf (publisher's version ) (Closed access

Immunocytokines: the long awaited therapeutic magic bullet in rheumatoid arthritis?

Loo, F.A.J. van de
Berg, W.B. van den

January 2009

Contains fulltext : 80373.pdf (publisher's version ) (Open Access

Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy

Pretto, Francesca
Elia, Giuliano
Castioni, Nadia
Neri, Dario

September 2014

Antibody-cytokine fusion proteins (“immunocytokines”) represent a promising class of armed antibody ...

Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma.

Brouwers, A.H.
Frielink, C.
Oosterwijk, E.
Oyen, W.J.G.
Corstens, F.H.M.
Boerman, O.C.

January 2003

Item does not contain fulltextBACKGROUND: Interleukin-2 (IL-2) and interferon-alpha (IFN-alpha) can ...

Molecularly defined dendritic cell-targeted vaccines for cancer immunotherapy

Fennemann, F.L.

January 2021

Contains fulltext : 235389.pdf (Publisher’s version ) (Open Access)Radboud Univers...